Return to program book search

Session Information

FRM F142 - Therapeutic Safety

Open admission to eligible categories, no tuition or ticket

Subject:

Date: Tuesday, March 05

CME Credits: 2.00

Location: Room A108/109

Time: 10:00 AM - 12:00 PM

Director: James Selwyn Taylor, MD, FAAD

Speakers:

  • David R. Adams, MD, PharmD, FAAD - Handout
  • Karen E. Edison, MD, FAAD
  • Hillary Johnson-Jahangir, MD, PhD, FAAD
  • Mario E. Lacouture, MD, FAAD
  • Patrick E. McCleskey, MD, FAAD - Handout

Learning Objectives:
Following this course, the attendee should be able to:

  • 1. Develop improved outcomes though better patient education and analyze essential therapeutic safety issues in procedural dermatology, including perioperative safety and adverse effects of topical anesthetics.
  • 2. Evaluate current guidelines for methotrexate therapy and the newer approaches to prevent chemotherapy-induced skin reactions.
  • 3. Examine your own practice to identify those therapeutic safety principles which you can improve or implement tomorrow

Description:
We will discuss important therapeutic safety issues in medical and procedural dermatology including general concepts and specific topics. Direct patient engagement in therapeutic decisions and better health literacy will improve outcomes. Therapeutic safety issues in procedural dermatology include patient misidentification, wrong site surgery, use of photographs, medication errors and sharps injuries. Factors associated with increased cutaneous and systemic toxicity after application of topical anesthetics will be reviewed. Current methotrexate guidelines will be discussed followed by a review of the new field of supportive oncodermatology and preventing adverse events to cancer therapy. Time for questions is included after each presentation.

Schedule:

Tuesday, March 05
10:00 AMIntroduction / Dr. Taylor
10:02 AMEducate Your Patient and Improve Outcomes: Health Literacy for Dermatologists / Dr. Edison
10:30 AMTherapeutic Safety: Procedural Dermatology / Dr. Johnson-Jahangir
10:55 AMComfortably Numb: Topical Anesthesia Risks and Guidelines / Dr. McCleskey
11:15 AMMethotrexate Guidelines / Dr. Adams
11:35 AMOncodermatology: Preventive Measures for Chemotherapy-Induced Skin Reactions / Dr. Lacouture